Exact Mass: 243.9855
Exact Mass Matches: 243.9855
Found 432 metabolites which its exact mass value is equals to given mass value 243.9855
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Fucose 1-phosphate
Fucose 1-phosphate (CAS: 16562-58-6) belongs to the class of organic compounds known as monosaccharide phosphates. These are monosaccharides comprising a phosphate group linked to the carbohydrate unit. Fucose 1-phosphate is an intermediate in the reversible synthesis of GDP-L-fucose catalyzed by the enzyme guanosine triphosphate fucose pyrophosphorylase (GFPP, EC 2.7.7.30). The reversible reaction is magnesium-dependent, although the enzyme is partially active when cobalt or manganese is substituted. The reaction is unusual in that, of the four canonical nucleoside triphosphates, only guanosine can be utilized efficiently to form a nucleotide-sugar. Free cytosolic fucose is phosphorylated by L-fucokinase (EC 2.7.1.52) to form fucose-1-phosphate in the salvage pathway of GDP-L-fucose (PMID: 16185085, 14686921). Fucose-1-phosphate is an intermediate in the reversible synthesis of GDP-L-fucose, in a reaction catalyzed by the enzyme guanosine triphosphate fucose pyrophosphorylase (GFPP, E.C. 2.7.7.30) . The reversible reaction is magnesium-dependent, although the enzyme is partially active when cobalt or manganese is substituted. The reaction is unusual in that, of the four canonical nucleoside triphosphates, only guanosine can be utilized efficiently to form a nucleotide-sugar. Free cytosolic fucose is phosphorylated by L-fucokinase (EC 2.7.1.52) to form fucose-1-phosphate in the salvage pathway of GDP-L-fucose. (PMID: 16185085, 14686921) [HMDB]
Apraclonidine
Apraclonidine is only found in individuals that have used or taken this drug.Apraclonidine, also known as iopidine, is a sympathomimetic used in glaucoma therapy.Apraclonidine is a relatively selective alpha2 adrenergic receptor agonist that stimulates alpha1 receptors to a lesser extent. It has a peak ocular hypotensive effect occurring at two hours post-dosing. The exact mechanism of action is unknown, but fluorophotometric studies in animals and humans suggest that Apraclonidine has a dual mechanism of action by reducing aqueous humor production through the constriction of afferent ciliary process vessels, and increasing uveoscleral outflow. S - Sensory organs > S01 - Ophthalmologicals > S01E - Antiglaucoma preparations and miotics > S01EA - Sympathomimetics in glaucoma therapy C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists
L-Rhamnulose 1-phosphate
A deoxyketohexose phosphate consisting of L-rhamnulose having a monophosphate group at the 1-position.
2-Hydroxy-2-(hydroxymethyl)-3-oxo-4-phosphonooxybutanoic acid
p-Coumaric acid sulfate
p-Coumaric acid sulfate (CAS: 376374-66-2) is an endogenous phenolic acid metabolite. p-Coumaric acid sulfate was found to be elevated in rat urine after whole rye consumption which makes this compound a potential urinary biomarker of whole grain intake (PMID: 26862900). BioTransformer predicts that p-coumaric acid sulfate is a product of p-coumaric acid metabolism via a 4-O-sulfation-of-phenolic-compound reaction catalyzed by sulfotransferase 1A3 (P0DMM9) and sulfotransferase enzymes (PMID: 30612223).
(2E)-3-[3-(sulfooxy)phenyl]prop-2-enoic acid
(2e)-3-[3-(sulfooxy)phenyl]prop-2-enoic acid is a predicted metabolite generated by BioTransformer¹ that is produced by the metabolism of (2e)-3-(3-hydroxyphenyl)prop-2-enoic acid. It is generated by Sulfotransferase 1A3 (P0DMM9) and Sulfotransferase enzymes via a -3-O-sulfation-of-phenolic-compound reaction. This -3-O-sulfation-of-phenolic-compound occurs in humans.
2-Deoxy-D-arabino-hexose 6-(dihydrogen phosphate)
4-chloro-3,4-dihydro-5,6,8-trihydroxy-3-methylisocoumarin
3-(hydroxyprop-1-ynyl)-6-(5-hexen-3-yn-1-ynyl)-1,2-dithiacyclohexa-3,5-diene|4,7-Epidithio-4,6,12-tridecatriene-2,8,10-triyn-1-ol
Ketone-2,3-Dihydro-5-[[5-(1-propynyl)-2-thienyl]ethynyl]thiophen-3-ol
3-(1-propynyl)-6-(5-hexen-3-yn-1-ynyl)-cyclohexa-3,5-diene-1,2-thiosulphinate|Thiarubrin 1-oxide
3-(1-propynyl)-6-(5,6-epoxyhex-3-yn-1-ynyl)-1,2-dithiacyclohexa-3,5-diene|3-[4-(2-Oxiranyl)-1,3-butadiynyl]-6-(1-propynyl)-1,2-dithiin|thiarubrine D
alpha-L-(-)-Fucose 1-phosphate bis(cyclohexylammonium) salt
acetazolamide sodium
C471 - Enzyme Inhibitor > C29577 - Carbonic Anhydrase Inhibitor C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic
5-(5-Bromothiazol-2-yl)-1-methyl-1H-[1,2,4]triazole
(S)-(6-BROMO-2,3-DIHYDROBENZO[B][1,4]DIOXIN-2-YL)METHANOL
6-CHLORO-2-METHYL-1,2,3,4-TETRAHYDRO-1LAMBDA6-BENZOTHIINE-1,1,4-TRIONE
N-((5-bromopyridin-3-yl)methyl)-2-methoxyethanamine
3-AMINO-3-(5-CHLORO-2-NITRO-PHENYL)-PROPIONIC ACID
METHYL 4-ACETYL-3-METHYL-5-(METHYLTHIO)THIOPHENE-2-CARBOXYLATE
7-CHLORO-3-OXO-3,4-DIHYDRO-2H-PYRIDO[3,2-B][1,4]THIAZINE-6-CARBOXYLIC ACID
(R)-(6-BROMO-2,3-DIHYDROBENZO[B][1,4]DIOXIN-2-YL)METHANOL
2-CHLORO-4-(TRIFLUOROMETHYL)PYRIMIDINE-5-CARBONYL CHLORIDE
2-thiophen-3-yl-3H-benzimidazole-5-carboxylic acid
2-THIOPHEN-2-YL-3H-BENZOIMIDAZOLE-4-CARBOXYLIC ACID
4-Chloro-2-(4-oxo-piperidinyl)-5-thiazolecarboxaldehyde
[4-(trifluoromethyl)thiophen-2-yl]hydrazine,hydrochloride
3-Chloro-6-methylbenzothiophene-2-carbonyl chloride
2-THIOPHEN-2-YL-1H-BENZOIMIDAZOLE-5-CARBOXYLIC ACID
5-(1H-BENZOIMIDAZOL-2-YLSULFANYL)-FURAN-2-CARBALDEHYDE
2-chloro-N-(6-fluoro-1,3-benzothiazol-2-yl)acetamide
N-(5-bromo-2-pyrimidinyl)-N,N-dimethylethane-1,2-diamine
2-chloro-1-(2,3-dihydro-1,4-benzodithiin-6-yl)ethanone
3-Bromo-6-chloro-4-methyl-1H-pyrrolo[2,3-b]pyridine
3-Bromo-4-chloro-2-methyl-1H-pyrrolo[2,3-b]pyridine
1H-Pyrrolo[2,3-b]pyridine, 4-bromo-5-chloro-2-Methyl-
Benzenemethanol, alpha,alpha-bis(trifluoromethyl)-
2-[(4-chlorophenyl)sulfonyl]-2-hydroxyiminoacetonitrile
Methyl 2-(2,6-dichloro-3-cyanopyridin-4-yl)acetate
methyl 4,6-dichloro-1H-pyrrolo[3,2-c]pyridine-2-carboxylate
Arsonium,(2-hydroxyethyl)trimethyl-, bromide (1:1)
1H-Pyrrolo[2,3-b]pyridine-1-carboxylic acid, 4,6-dichloro-, methyl ester
(3-(3-CHLOROPHENYL)ISOXAZOL-5-YL)METHANAMINE HYDROCHLORIDE
Imidazo[1,2-a]pyridine-7-carboxylic acid, 2-(2-thienyl)
1-(4,5-DIHYDRO-1H-IMIDAZOL-2-YL)-3,5-DIMETHYL-1H-PYRAZOLE HYDROBROMIDE
poassium 3-methoxyethylether phenyl trifluoroborate
(2-Chloro-4-methoxy-5-(methoxycarbonyl)phenyl)boronic acid
1-(difluoromethyl)-3,5-dimethylpyrazole-4-sulfonyl chloride
3-AMINO-3-(4-CHLORO-3-NITRO-PHENYL)-PROPIONIC ACID
5,11-bisthio-(R,R)-1,7-diazatricyclo[7.3.0.07,11]dodecane-2,8-diketone
Methyl 7-(trifluoromethyl)-1-benzofuran-2-carboxylate
Iron,tricarbonyl[(1,2,3,4-h)-1,3,5,7-cyclooctatetraene]-
1-Methyl-3-oxo-1,3-dihydro-benzo[c]isothiazole-5-sulfonic acid amide
Ferric nitrilotriacetate
D006401 - Hematologic Agents > D006397 - Hematinics > D005290 - Ferric Compounds D009676 - Noxae > D002273 - Carcinogens D009676 - Noxae > D009153 - Mutagens
2-{[(2-chloro-6-fluorophenyl)methyl]sulfanyl}-4,5-dihydro-1H-imidazole
[(3S,4R,5S)-3,4,5-trihydroxy-2-keto-hexyl] dihydrogen phosphate
alpha-oxo-1-carboxy-5,6-dihydrothiopyranpropanoate S-oxide
[Phosphonoamino-(2-sulfoethylamino)methylene]ammonium
[(2S,4S,5S)-4-hydroxy-5-(methylsulfanylmethyl)oxolan-2-yl] dihydrogen phosphate
8-chloro-1-methyl-2,6-dioxo-7H-purine-3-carboxylic acid
[(2S,3S,4S,5S)-3,4,5,6-tetrahydroxyoxan-2-yl]methanesulfonic acid
[(2S,3S,4S,5S,6R)-3,4,5,6-tetrahydroxyoxan-2-yl]methanesulfonic acid
apraclonidine
S - Sensory organs > S01 - Ophthalmologicals > S01E - Antiglaucoma preparations and miotics > S01EA - Sympathomimetics in glaucoma therapy C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists
6-deoxy-6-sulfo-D-fructofuranose
A carbohydrate sulfonate that is D-fructofuranose in which the hydroxy group at at position 6 is replaced by a sulfo group.
2-Deoxy-D-glucose 6-phosphate
A deoxyaldohexose phosphate comprising 2-deoxy-D-glucose having the phosphate group at the 6-position.
4-(sulfooxy)-cinnamic acid
An aryl sulfate that is (2E)-3-phenylprop-2-enoic acid which is substituted by a sulfooxy group at position 4. It is produced by the seagrass Zostera marina and has very promising antifouling potential against several micro- and macrofouling organisms.
3-(3-sulfooxyphenyl)propanoate(2-)
A 3-(3-sulfooxyphenyl)propanoic acid anion obtained by deprotonation of the carboxy and sulfo groups of 3-(3-sulfooxyphenyl)propanoic acid.
6-sulfo-beta-D-quinovose
A 6-sulfo-D-quinovose (6-deoxy-6-sulfo-D-glucopyranose) that has beta configuration at the anomeric centre.
6-sulfo-alpha-D-quinovose
A 6-sulfo-D-quinovose that has alpha configuration at the anomeric centre.
6-Sulfo-d-quinovose
A carbohydrate sulfonate that is D-quinovose (6-deoxy-D-glucose) in which one of the methyl hydrogens at position 6 is replaced by a sulfo group.
ZAPA (sulfate)
ZAPA sulfate is an agonist at low affinity GABAA-receptors. ZAPA sulfate induces membrane hyperpolarization of the Ascaris muscle cell with an EC50 of 10.3 μM[1][2].